NCT04727008View on ClinicalTrials.gov

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

CXCR4 modified anti-BCMA CAR T cells

intravenous infusion

Trial Locations (1)

610041

RECRUITING

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER